COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

bioRxiv posts many COVID19-related papers. A reminder: they have not been formally peer-reviewed and should not guide health-related behavior or be reported in the press as conclusive.

29,828 Articles (21,997 medRxiv, 7,831 bioRxiv)

Most recent first Previous |  Page 2861: Articles 28601-28610  | Next

The impacts of diagnostic capability and prevention measures on transmission dynamics of COVID-19 in Wuhan
LIANG, J., Yuan, H.-Y.
10.1101/2020.03.31.20049387 — Posted: 2020-04-06
Monitoring Italian COVID-19 spread by an adaptive SEIRD model
Loli Piccolomiini, E., Zama, F.
10.1101/2020.04.03.20049734 — Posted: 2020-04-06
Aerosol-spread during chest compressions in a cadaver model
Ott, M., Milazzo, A., Liebau, S., Wagner, A., Jaki, C., Schilling, T., Krohn, A., Heymer, J.
10.1101/2020.03.31.20049197 — Posted: 2020-04-06
No indications for overt innate immune suppression in critically ill COVID-19 patients
Kox, M., Frenzel, T., Schouten, J., van de Veerdonk, F., Koenen, H. J. P. M., Pickkers, P., RCI-COVID-19 study group
10.1101/2020.04.03.20049080 — Posted: 2020-04-06 Discussion: Offsite
Projection of COVID-19 Pandemic in Uganda
Mbabazi, F. K.
10.1101/2020.04.02.20051086 — Posted: 2020-04-06
Optimal COVID-19 epidemic control until vaccine deployment
Djidjou-Demasse, R., Michalakis, Y., Choisy, M., Sofonea, M. T., Alizon, S.
10.1101/2020.04.02.20049189 — Posted: 2020-04-06
Facemasks and similar barriers to prevent respiratory illness such asCOVID-19: A rapid systematic review
Brainard, J. S., Jones, N., Lake, I., Hooper, L., Hunter, P.
10.1101/2020.04.01.20049528 — Posted: 2020-04-06 Discussion: Onsite
Differential COVID-19-attributable mortality and BCG vaccine use in countries
Shet, A., Ray, D., Malavige, N., Santosham, M., Bar-Zeev, N.
10.1101/2020.04.01.20049478 — Posted: 2020-04-06 Discussion: Onsite | Offsite
Building an International Consortium for Tracking Coronavirus Health Status
Segal, E., Zhang, F., Lin, X., King, G., Shalem, O., Shilo, S., Allen, W. E., Grad, Y. H., Greene, C. S., Alquaddoomi, F., Anders, S., Balicer, R., Bauman, T., Bonilla, X., Booman, G., Chan, A. T., Ori Cohen, O., Coletti, S., Davidson, N., Dor, Y., Drew, D. A., Elemento, O., Evans, G., Ewels, P., Gale, J., Gavrieli, A., Geiger, B., Hajirasouliha, I., Jerala, R., Kahles, A., Kallioniemi, O., Keshet, A., Landua, G., Meir, T., Muller, A., Nguyen, L. H., Oresic, M., Ovchinnikova, S., Peterson, H., Rajagopal, J., Ratsch, G., Rossman, H., Rung, J., Sboner, A., Sigaras, A., Spector, T., Steinherz, R., Stevens, I., Vilo, J., Wilmes, P., CCC (Coronavirus Census Collective)
10.1101/2020.04.02.20051284 — Posted: 2020-04-06
Perceived vulnerability to COVID-19 infection from event attendance: Results from Louisiana, USA, two weeks preceding the national emergency declaration
Li, R., Yang, B., Penn, J., Houghtaling, B., Chen, J., Prinyawiwatkul, W., Roe, B., Qi, D.
10.1101/2020.04.01.20049742 — Posted: 2020-04-06

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).